Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication ofHelicobacter pylori
- 4 October 2012
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 28 (1) , 78-83
Abstract
Background and Aim Pepsinogen (PG) method is widely used to identify high risk groups of gastric cancer. It is very useful before Helicobacter pylori eradication, but after eradication the method becomes useless because the PGI, PGII, PGI/II ratios change. Therefore, we aimed to identify a high risk group for gastric cancer using serum pepsinogen after successful eradication of H. pylori. Methods A total of 261 participants were enrolled after successful eradication of H. pylori in Hokkaido University Hospital from 1995 to 2010. Participants with renal failure, taking proton pump inhibitors, and those with advanced gastric cancer were excluded. Serum levels of PGI and II were measured using chemiluminescent immunoassay method. Results Receiver operating characteristic curves using cancerous and non‐cancerous data in post‐eradication determined the optimal cut‐off value of PGI/II as 4.5. The sensitivity and the specificity were 65.9% and 79.3%, respectively. The usual PG method includes 48.9% of cancer cases, and the PGI/II ≤ 4.5 in post‐eradication includes 65.9% of them, and it includes approximately half of the high risk group of diffuse type cancer. PGI/II ≤ 4.5 in post‐eradication included many gastric cancer cases detected after eradication (12/16 = 75%). Conclusion In the identification of a high risk group for gastric cancer, we suggest that the optimal cut‐off value of PGI/II after successful eradication of H. pylori is 4.5. PGI/II ≤ 4.5 in post‐eradication includes more gastric cancer cases compared with the traditional PG method, and 75% of gastric cancer cases detected after eradication.Keywords
This publication has 29 references indexed in Scilit:
- Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged MalesCancer Epidemiology, Biomarkers & Prevention, 2008
- Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resectionJournal of Gastroenterology, 2007
- Gastritis staging in clinical practice: the OLGA staging systemGut, 2006
- Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control StudyCancer Epidemiology, Biomarkers & Prevention, 2006
- Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspepticsBritish Journal of Cancer, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Serum pepsinogens as markers of response to therapy forHelicobacter pylori gastritisDigestive Diseases and Sciences, 1993
- The Effect of Vagotomy and Antrectomy on Serum Pepsinogens I and IIScandinavian Journal of Gastroenterology, 1990
- The Ratio of Pepsinogen A to Pepsinogen C: A Sensitive Test for Atrophic GastritisScandinavian Journal of Gastroenterology, 1989
- Prospective Study of the Effect of Gastrectomy with and without Bile Reflux on Serum PepsinogensDigestion, 1989